Viking Therapeutics (1VT)

As of Oct 22, 2026, ORTEX estimated 7.1% of free float sold short, 10,583.9 days to cover, cost to borrow 0.49%. Sign up for live short interest data.

Market Cap

3.42b USD | # 3079 in DE

Volume

818 shares | 52.73k USD

Shares Outstanding

127.52m

Free Float Shares

97.71% | 124.6m

Nasdaq:VKTX|

DB:1VT|

LSE:0VQA|

BIT:1VKTX

News

1VT key data

Viking Therapeutics (XTRA: 1VT) has a market capitalization of $3.42B. Last close €23.80 (as of 2026-11-09); 52-week range €21.60 to €39.05. ORTEX data as of 2026-10-22: short interest was 7.06% of free float, 10,583.9 days to cover and the average cost to borrow was 0.49%. Sign up for live short interest data.